B · Normal
[Hong Kong Stock IPO: Zhejiang Jingxin Pharmaceutical Co., Ltd. submitted to the Hong Kong Stock Exchange] On September 18, Livermore Securities showed that Zhejiang Jingxin Pharmaceutical Co., Ltd. submitted a listing application to the Hong Kong Stock Exchange, and the exclusive sponsor was CITIC Securities.
Comments